SIBN · SI-BONE, Inc. · Earnings Call Transcripts & Audio
$18.80
-0.35 (-1.83%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$833.18M
Shares
44.82M
Volume · Sep 30
640.21K
Avg daily vol (3M)
553.41K
SI-BONE, Inc. Earnings Call Transcripts
Quarterly earnings calls for SI-BONE, Inc. (SIBN), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲18.6%
$26.43M
−$14.16M
'22 Q3
22-11-07
▲26.6%
$31.95M
−$11.18M
'22 Q4
23-01-09
▲45.8%
$32.71M
−$11.12M
'23 Q1
23-05-01
▲30.2%
$33.30M
−$11.21M
'23 Q2
23-08-07
▲28.7%
$34.01M
−$10.02M
'23 Q3
23-11-06
▲21.6%
$38.86M
−$10.98M
'23 Q4
24-02-26
▲15.8%
$37.87M
−$10.90M
'24 Q1
24-05-06
▲20%
$39.97M
−$8.94M
'24 Q2
24-08-05
▲18.6%
$40.34M
−$6.58M
'24 Q3
24-11-12
▲26.1%
$49.00M
−$4.50M
'24 Q4
25-02-24
▲24.9%
$47.29M
−$6.54M
'25 Q1
25-05-05
▲21.7%
$48.63M
−$6.15M
'25 Q2
25-08-04
▲20.6%
$48.66M
−$4.57M
'25 Q3
25-11-10
▲15%
$56.35M
−$1.64M
'25 Q4
26-02-23
▲11.2%
$52.59M
−$4.33M
'26 Q1
26-05-11
LATEST
▲15.2%
$56.01M
−$4.09M
'26 Q2
26-08-03
Conference
Investor event
2026-09-14
SI-BONE, Inc. (SIBN) September 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-08-03
SI-BONE, Inc. (SIBN) Q2 2026 Earnings Call Transcript
Confident tone
Financial performance / profitability
Reimbursement tailwinds
Product portfolio expansion
Revenue
$56.01M
▲ 15.2% YoY Diluted EPS
$-0.09
Gross margin
79.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-11
SI-BONE, Inc. (SIBN) Q1 2026 Earnings Call Transcript
Confident tone
Revenue growth and geographic expansion
Product launches and platform expansion
Reimbursement and CMS DRG proposal
Revenue
$52.59M
▲ 11.2% YoY Diluted EPS
$-0.10
Gross margin
79.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-23
SI-BONE, Inc. (SIBN) Q4 2025 Earnings Call Transcript
Confident tone
Physician Engagement and Adoption
Innovation and Product Launches
Smith & Nephew Distribution Partnership
Revenue
$56.35M*
▲ 15% YoY Gross margin
79.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-10
SI-BONE, Inc. (SIBN) Q3 2025 Earnings Call Transcript
Confident tone
Product pipeline and 2026 launches
Operational leverage and operating discipline
Reimbursement tailwinds
Revenue
$48.66M
▲ 20.6% YoY Diluted EPS
$-0.11
Gross margin
79.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-04
SI-BONE, Inc. (SIBN) Q2 2025 Earnings Call Transcript
Confident tone
Physician adoption and surgeon base expansion
Granite pelvic fixation platform
Pelvic trauma / TNT with FDA breakthrough designation
Revenue
$48.63M
▲ 21.7% YoY Diluted EPS
$-0.14
Gross margin
79.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-05
SI-BONE, Inc. (SIBN) Q1 2025 Earnings Call Transcript
Confident tone
Product Innovation and Pipeline
Sales Force Productivity and Expansion
Operational Leverage and Path to GAAP Profitability
Revenue
$47.29M
▲ 24.9% YoY Diluted EPS
$-0.15
Gross margin
79.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-24
SI-BONE, Inc. (SIBN) Q4 2024 Earnings Call Transcript
Confident tone
Product Portfolio Launches (Granite 9.5, TNT, TORQ, INTRA)
Revenue Growth and Financial Performance
Active Physician Expansion and Engagement
Revenue
$49.00M*
▲ 26.1% YoY Gross margin
79.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-12
SI-BONE, Inc. (SIBN) Q3 2024 Earnings Call Transcript
Confident tone
New product launches and pipeline
Profitability and operating leverage
Reimbursement and NTAP
Revenue
$40.34M
▲ 18.6% YoY Diluted EPS
$-0.16
Gross margin
79.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-05
SI-BONE, Inc. (SIBN) Q2 2024 Earnings Call Transcript
Confident tone
Interventional spine market opportunity
Product portfolio expansion (Granite 9.5, TORQ, iFuse)
Physician engagement and training
Revenue
$39.97M
▲ 20% YoY Diluted EPS
$-0.22
Gross margin
79.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-06
SI-BONE, Inc. (SIBN) Q1 2024 Earnings Call Transcript
Confident tone
Product portfolio expansion (Granite 9.5, TORQ, INTRA)
Revenue growth and procedure demand
Seasonality and conservatism in outlook
Revenue
$37.87M
▲ 15.8% YoY Diluted EPS
$-0.27
Gross margin
78.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-26
SI-BONE, Inc. (SIBN) Q4 2023 Earnings Call Transcript
Confident tone
Interventionalist Expansion and Allograft Opportunity
Clinical Evidence and Studies
Product Launches and Portfolio Expansion
Revenue
$38.86M*
▲ 21.6% YoY Gross margin
73.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-06
SI-BONE, Inc. (SIBN) Q3 2023 Earnings Call Transcript
Revenue
$34.01M
▲ 28.7% YoY Diluted EPS
$-0.25
Gross margin
79.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-07
SI-BONE, Inc. (SIBN) Q2 2023 Earnings Call Transcript
Revenue
$33.30M
▲ 30.2% YoY Diluted EPS
$-0.30
Gross margin
81.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-01
SI-BONE, Inc. (SIBN) Q1 2023 Earnings Call Transcript
Revenue
$32.71M
▲ 45.8% YoY Diluted EPS
$-0.32
Gross margin
81.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-01-09
SI-BONE, Inc. (SIBN) Q4 2022 Earnings Call Transcript
Revenue
$31.95M*
▲ 26.6% YoY Gross margin
84.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-07
SI-BONE, Inc. (SIBN) Q3 2022 Earnings Call Transcript
Revenue
$26.43M
▲ 18.6% YoY Diluted EPS
$-0.41
Gross margin
84.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-08
SI-BONE, Inc. (SIBN) Q2 2022 Earnings Call Transcript
Revenue
$25.59M
▲ 15.3% YoY Diluted EPS
$-0.54
Gross margin
86.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-09
SI-BONE, Inc. (SIBN) Q1 2022 Earnings Call Transcript
Revenue
$22.44M
▲ 9.8% YoY Diluted EPS
$-0.52
Gross margin
86.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-01-10
SI-BONE, Inc. (SIBN) Q4 2021 Earnings Call Transcript
Revenue
$25.23M*
▲ 13.9% YoY Gross margin
86.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-08
SI-BONE, Inc. (SIBN) Q3 2021 Earnings Call Transcript
Revenue
$22.29M
▲ 9.4% YoY Diluted EPS
$-0.48
Gross margin
88.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-02
SI-BONE, Inc. (SIBN) Q2 2021 Earnings Call Transcript
Revenue
$22.19M
▲ 58% YoY Diluted EPS
$-0.42
Gross margin
89.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-03
SI-BONE, Inc. (SIBN) Q1 2021 Earnings Call Transcript
Revenue
$20.44M
▲ 21.5% YoY Diluted EPS
$-0.37
Gross margin
89.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-08
SI-BONE, Inc. (SIBN) Q4 2020 Earnings Call Transcript
Revenue
$22.14M*
▲ 11.8% YoY Gross margin
89.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-02
SI-BONE, Inc. (SIBN) Q3 2020 Earnings Call Transcript
Revenue
$20.37M
▲ 25.9% YoY Diluted EPS
$-0.33
Gross margin
87.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-03
SI-BONE, Inc. (SIBN) Q2 2020 Earnings Call Transcript
Revenue
$14.05M
▼ 13.9% YoY Diluted EPS
$-0.44
Gross margin
84.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-04
SI-BONE, Inc. (SIBN) Q1 2020 Earnings Call Transcript
Revenue
$16.82M
▲ 12.2% YoY Gross margin
88.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-01-09
SI-BONE, Inc. (SIBN) Q4 2019 Earnings Call
Revenue
$19.81M*
▲ 26.8% YoY Gross margin
89.7%
Rev · 7q
Audio
Transcript
Slides
8-K10-K
Showing 1–28 of 28 earnings calls